Commit To Purchase Allogene Therapeutics At $2, Earn 52.1% Annualized Using Options
August 02, 2024 at 11:35 AM EDT
Investors considering a purchase of Allogene Therapeutics Inc (ALLO) stock, but tentative about paying the going market price of $2.52/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $2 strike, which has a bid at the time of this writing of 30 cents..